BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24616064)

  • 1. Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.
    Rosenkrantz AB; Triolo MJ; Melamed J; Rusinek H; Taneja SS; Deng FM
    J Magn Reson Imaging; 2015 Mar; 41(3):708-14. PubMed ID: 24616064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer.
    Krishna S; Lim CS; McInnes MDF; Flood TA; Shabana WM; Lim RS; Schieda N
    J Magn Reson Imaging; 2018 Jan; 47(1):176-185. PubMed ID: 28387981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.
    Rosenkrantz AB; Ream JM; Nolan P; Rusinek H; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2015 Dec; 205(6):1208-14. PubMed ID: 26587927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
    Lim C; Flood TA; Hakim SW; Shabana WM; Quon JS; El-Khodary M; Thornhill RE; El Hallani S; Schieda N
    J Magn Reson Imaging; 2016 Mar; 43(3):726-36. PubMed ID: 26303719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient.
    Donati OF; Mazaheri Y; Afaq A; Vargas HA; Zheng J; Moskowitz CS; Hricak H; Akin O
    Radiology; 2014 Apr; 271(1):143-52. PubMed ID: 24475824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADC Metrics From Multiparametric MRI: Histologic Downgrading of Gleason Score 9 or 10 Prostate Cancers Diagnosed at Nontargeted Transrectal Ultrasound-Guided Biopsy.
    Sadoughi N; Krishna S; McInnes MDF; Flood TA; Breau RH; Morash C; Schieda N
    AJR Am J Roentgenol; 2018 Sep; 211(3):W158-W165. PubMed ID: 29995495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen.
    De Cobelli F; Ravelli S; Esposito A; Giganti F; Gallina A; Montorsi F; Del Maschio A
    AJR Am J Roentgenol; 2015 Mar; 204(3):550-7. PubMed ID: 25714284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of prostate cancer lesions with high and with low Gleason score by diffusion-weighted MRI.
    Barbieri S; Brönnimann M; Boxler S; Vermathen P; Thoeny HC
    Eur Radiol; 2017 Apr; 27(4):1547-1555. PubMed ID: 27300199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
    Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.
    Rozenberg R; Thornhill RE; Flood TA; Hakim SW; Lim C; Schieda N
    AJR Am J Roentgenol; 2016 Apr; 206(4):775-82. PubMed ID: 27003049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI of the Prostate With and Without Endorectal Coil at 3 T: Correlation With Whole-Mount Histopathologic Gleason Score.
    Dhatt R; Choy S; Co SJ; Ischia J; Kozlowski P; Harris AC; Jones EC; Black PC; Goldenberg SL; Chang SD
    AJR Am J Roentgenol; 2020 Jul; 215(1):133-141. PubMed ID: 32160050
    [No Abstract]   [Full Text] [Related]  

  • 12. Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores.
    Wibmer A; Hricak H; Gondo T; Matsumoto K; Veeraraghavan H; Fehr D; Zheng J; Goldman D; Moskowitz C; Fine SW; Reuter VE; Eastham J; Sala E; Vargas HA
    Eur Radiol; 2015 Oct; 25(10):2840-50. PubMed ID: 25991476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology.
    Boesen L; Chabanova E; Løgager V; Balslev I; Thomsen HS
    J Magn Reson Imaging; 2015 Aug; 42(2):446-53. PubMed ID: 25408104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes.
    Abreu-Gomez J; Walker D; Alotaibi T; McInnes MDF; Flood TA; Schieda N
    Eur Radiol; 2020 Aug; 30(8):4251-4261. PubMed ID: 32211965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive role of PI-RADSv2 and ADC parameters in differentiating Gleason pattern 3 + 4 and 4 + 3 prostate cancer.
    Alessandrino F; Taghipour M; Hassanzadeh E; Ziaei A; Vangel M; Fedorov A; Tempany CM; Fennessy FM
    Abdom Radiol (NY); 2019 Jan; 44(1):279-285. PubMed ID: 30066169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results.
    Nketiah G; Elschot M; Kim E; Teruel JR; Scheenen TW; Bathen TF; Selnæs KM
    Eur Radiol; 2017 Jul; 27(7):3050-3059. PubMed ID: 27975146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
    Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
    Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
    Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
    Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy.
    Verma S; Rajesh A; Morales H; Lemen L; Bills G; Delworth M; Gaitonde K; Ying J; Samartunga R; Lamba M
    AJR Am J Roentgenol; 2011 Feb; 196(2):374-81. PubMed ID: 21257890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.